瘤细胞产生的互白素-2绕过了T辅助功能,从而产生抗瘤反应
E R Fearon1, D M Pardoll, T Itaya
1Department of Oncology School of Medicine, Johns Hopkins University, Baltimore, Maryland 21205.
Cell
|February 9, 1990
概括
机械瘤细胞分泌介质素-2 (IL-2) 刺激了强大的抗瘤免疫反应,表明免疫缺陷,而不是缺乏效应细胞,阻碍了癌症免疫力. 这种方法为增强抗瘤免疫提供了一种新的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 使用免疫性差的小鼠结肠癌模型,研究了抗瘤免疫的机制.
- 解决了针对已建立瘤的弱免疫反应的挑战.
研究的目的:
- 探索增强抗瘤免疫力的新策略.
- 为了确定瘤细胞的细胞因子分泌能否刺激有效的免疫反应.
主要方法:
- 瘤细胞的基因转移以分泌互白素-2 (IL-2).
- 在体内研究评估抗瘤反应和保护瘤挑战.
- 在有或没有CD4+T细胞的情况下对免疫反应的评估.
主要成果:
- IL-2分泌的瘤细胞诱导了一种主要的组织相容性复合体 (MHC) 类I-受限制的细胞分解性T淋巴细胞 (CTL) 反应.
- 在体内观察到抗瘤反应,即使没有CD4+T细胞.
- 用工程细胞免疫接种提供了对随后的瘤挑战的保护.
结论:
- 有效抗瘤免疫的首要限制可能是免疫辅助功能的缺陷,而不是缺乏细胞毒性效应细胞.
- 助手淋巴蛋白的副供应可以诱导瘤特异性免疫反应.
- 这一策略为增强瘤免疫力提供了一种新的方法.
相关概念视频
Cell-mediated Immune Responses
65.0K
Overview
65.0K
The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
T Cell Activation and Clonal Selection
13.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
13.7K
T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Cytotoxic T Cells-mediated Immune Response
7.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.1K
Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K


